Helogen plans two in-orbit biomanufacturing missions for October
Helogen · LambdaVision
Per Payload: Helogen plans two October orbital missions, making biopolymers on one and retina proteins with LambdaVision on the other.
what happened
Helogen plans to fly its HEL-IOS autonomous biomanufacturing platform on two separate missions in October, per Payload. The first will produce biopolymers for orthopedic applications such as shoulder rotator cuff and knee meniscus repair scaffolding on an unannounced reentry vehicle, with materials recovered afterward. The second, with partner LambdaVision, will manufacture proteins for artificial retinas aboard a D-Orbit spacecraft. Both missions launch on SpaceX vehicles. Helogen CEO Shishir Bankapur told Payload sterility, traceability, and accountability are the biggest challenges on each mission, and the company's HEL-IOS platform previously won a NASA TechLeap prize. Helogen plans eight missions total over the next 12 months, about three-quarters of them for its own internal product development.
why it matters
In-space biomanufacturing has mostly been single-demonstration territory; Helogen naming two concrete October missions with named payloads, a named partner, and a repeatable platform is a step toward treating orbital manufacturing as a production line rather than one-off experiments. Reusable reentry-vehicle and hosted-payload access (via D-Orbit) lowers the bar for other biomaterials companies to test in orbit without building their own spacecraft.
signal-to-noise
quick facts
- Companies
- Helogen, LambdaVision
- Category
- product
- Impact
- notable
- SNR
- 2 / 5
- Event date
- 2026-09-01
- Published
- 2026-09-01 17:27 UTC